Emmaus Life Sciences (EMMA) Revenue (2010 - 2026)
Emmaus Life Sciences' Revenue was $6.32 million in Q2 2026, up 124.3% from $2.82 million a year earlier and up 218.8% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Revenue (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Emmaus Life Sciences' Revenue was $15.53 million through Jun 30, 2026, up 11.0% year-over-year; for FY2025, it came in at $12.45 million, down 25.2% from FY2024.
- Revenue shows a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
- In earlier years, Revenue was $16.65 million in FY2024 (-43.7%), $29.6 million in FY2023 (+60.9%), $18.39 million in FY2022 (-10.8%) and $20.61 million in FY2021 (-11.0%).
- The Q2 2026 figure marks the highest quarterly Revenue since Q4 2023.
- Compared with a year earlier, Revenue was higher in three of the last eight quarters, with an average decline of 1.3%.
- The best year-over-year quarter for Revenue over five years was Q2 2023 (growth of 151.0%); the worst was Q1 2024 (a decline of 62.9%).
- Per Business Quant data, EMMA's Revenue in the three quarters before Q2 2026 was $1.98 million (Q1 2026), $3.85 million (Q4 2025) and $3.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Emmaus Life Sciences | 3.51 Mn | -2.79 Mn | 5.97 Mn | 6.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.32 Mn |
| Mar 31, 2026 | 1.98 Mn |
| Dec 31, 2025 | 3.85 Mn |
| Sep 30, 2025 | 3.38 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Dec 31, 2024 | 3.29 Mn |
| Sep 30, 2024 | 5.48 Mn |
| Jun 30, 2024 | 5.38 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | 7.07 Mn |
| Sep 30, 2023 | 5.02 Mn |
| Jun 30, 2023 | 10.76 Mn |
| Mar 31, 2023 | 6.75 Mn |
| Dec 31, 2022 | 5.93 Mn |
| Sep 30, 2022 | 4.94 Mn |
| Jun 30, 2022 | 4.29 Mn |
| Mar 31, 2022 | 3.23 Mn |
| Dec 31, 2021 | 3.02 Mn |
| Sep 30, 2021 | 5.77 Mn |
API Access
Emmaus Life Sciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();